SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Trump wants to create an “AI Force”: Gemini incident shows why security must change

Autonomous remediation won't arrive as a big red button

CTech's Book Review: You cannot defend what you cannot see or understand

Nashville summit connects Israeli healthtech startups with U.S. healthcare leaders

Buzz

Most popular

Daily

Weekly

1

Oracle co-CEO sells $3.4 million in shares as stock falls 56% one year after his appointment

2

Israeli defense giants head to Marrakech as Morocco deepens military ties

3

The Israeli entrepreneur who built a university for 271,000 students around the world

4

Island raises $400 million at $6.4 billion valuation as AI agents reshape enterprise security

5

Brookfield closes in on $2 billion deal for Nice’s Actimize

Glaucoma

4 stories about Glaucoma

מיכאל בלקין מוסף

The 83-year-old who sold his invention for $466 million, and still walks to work every morning

14.08.25|Roni Dori

Michael Belkin’s journey from rooftop experiments to global glaucoma breakthroughs proves some minds never retire.

דריה להמן-בלומנטל

The Israeli startup treating the silent thief of sight

30.01.22|Yafit Ovadia

BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness

דריה למאן בלומנטל מנכ״ל ארגון בלקין לייזר

Belkin Laser announces $12.2 million raised in series B funding

21.07.20|Hagar Ravet

The company is in the midst of clinical testing of its one-second glaucoma treatment with the product expected to enter the market in two years

BioLight ביולייט איי אופטימה IOPtima

Shenzhen-listed Pharma Company to Acquire Tel Aviv-based Medtech Company IOPtima

21.11.17|Lilach Baumer

The Chengdu Kanghong Pharma Group will buy Tel Aviv-based IOPtima in four stages, the latter announced Tuesday through its parent company listed on the Tel Aviv Stock Exchange